BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36477612)

  • 1. Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial.
    Xu C; Jiang S; Zou L; Sheng L; Shi G; Xu B; Wang Z; Xu D; Xie X; Luo J; Guo J; Jiang H
    Cancer; 2023 Feb; 129(3):415-425. PubMed ID: 36477612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?
    Volz Y; Trappmann R; Ebner B; Eismann L; Enzinger B; Hermans J; Pyrgidis N; Stief C; Schulz GB
    Urol Int; 2024; 108(1):42-48. PubMed ID: 37944501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS).
    Prasad SM; Huang WC; Shore ND; Hu B; Bjurlin M; Brown G; Genov P; Shishkov D; Khuskivadze A; Ganev T; Marchev D; Orlov I; Kopyltsov E; Zubarev V; Nosov A; Komlev D; Burger B; Raju S; Meads A; Schoenberg M
    J Urol; 2023 Oct; 210(4):619-629. PubMed ID: 37548555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transurethral holmium laser resection and transurethral electrocision combined with intravesical epirubicin within 24 hours postoperatively for treatment of bladder cancer.
    Lu J; Xue Y; Shen F; Gu H; Liu H; Hou J; Miao H
    J Int Med Res; 2020 Jun; 48(6):300060519887267. PubMed ID: 31885339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognosis and safety of continuous saline bladder irrigation in patients after transurethral resection of bladder tumors: a systematic review and meta-analysis of comparative study.
    Wang X; Wang Y; Che X; Zhou Z; Cheng B
    Updates Surg; 2023 Oct; 75(7):1795-1806. PubMed ID: 37188906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of in vivo Raman spectroscopy and cryoablation for diagnosis and treatment of bladder cancer.
    Liu Y; Ye F; Yang C; Jiang H
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Mar; 308():123707. PubMed ID: 38043292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Early Stage Bladder Carcinosarcoma in Late Recurrence of Urothelial Carcinoma after Transurethral Resection.
    Hirano D; Yoshida T; Funakoshi D; Sakurai F; Ohno S; Kusumi Y
    Case Rep Urol; 2018; 2018():1405108. PubMed ID: 29568660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS).
    Montorsi F; Moschini M; Gandaglia G; Briganti A
    J Urol; 2024 Mar; 211(3):482-483. PubMed ID: 38329052
    [No Abstract]   [Full Text] [Related]  

  • 9. Second transurethral resection in T1G3 bladder tumors - Selectively avoidable?
    Katumalla FS; Devasia A; Kumar R; Kumar S; Chacko N; Kekre N
    Indian J Urol; 2011 Apr; 27(2):176-9. PubMed ID: 21814305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carboxycryobiopsy and carboxycryoextraction of bladder tumor. Experimental study].
    Damiev AD; Shpot EV; Akopyan GN; Dymov AM; Kharchilava RR; Yandiev SA; Ismailov KM; Lerner YV; Kammaev KA; Gazimiev MA
    Urologiia; 2023 Sep; (4):24-29. PubMed ID: 37850277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial on the use of IMAGE1 S LIGHT (SPIES) vs. white light in the prevention of recurrence during transurethral resection of bladder tumors: Analysis after 12-month follow-up.
    Trelles Guzmán CR; Linares Espinós E; Ríos González E; Alonso Dorrego JM; Aguilera Bazán A; Jiménez Romero ME; Martínez-Piñeiro L
    Actas Urol Esp (Engl Ed); 2023 Dec; ():. PubMed ID: 38159804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Assessment of a Novel Endoscopic Ultrasound-Compatible Cryocatheter to Ablate Pancreatic Cancer.
    Baust JM; Robilotto A; Raijman I; Santucci KL; Van Buskirk RG; Baust JG; Snyder KK
    Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-Escalated Radiation Therapy as Primary Treatment for Residual Bladder Cancer After Transurethral Resection.
    Chang YC; Wu YY; Tsan DL; Yap WK; Fan KH; Chang JT; Shen EY
    Adv Radiat Oncol; 2024 Jan; 9(1):101302. PubMed ID: 38260237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating clinicians, knowledge and data: expert-based cooperative analysis in healthcare decision support.
    Gibert K; García-Alonso C; Salvador-Carulla L
    Health Res Policy Syst; 2010 Sep; 8():28. PubMed ID: 20920289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mulitcenter study on antibiotic prophylaxis, infectious complications and risk assessment in TUR-P.
    Schneidewind L; Kranz J; Schlager D; Barski D; Mühlsteadt S; Grabbert M; Queissert F; Frank T; Pelzer AE
    Cent European J Urol; 2017; 70(1):112-117. PubMed ID: 28461999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-Based Clinical Algorithm for Hypotonia Assessment: To Pardon the Errs.
    Govender P; Joubert RWE
    Occup Ther Int; 2018; 2018():8967572. PubMed ID: 29853815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical evaluation of an
    Golan S; Bar V; Salpeter SJ; Neev G; Creiderman G; Kedar D; Aharon S; Turovsky L; Zundelevich A; Shahar H; Shapira H; Mallel G; Stossel E; Gavert N; Straussman R; Dotan Z; Berger R; Stossel C; Golan T; Halperin S; Leibovici D; Breuer S; Rottenberg Y; Applebaum L; Hubert A; Nechushtan H; Peretz T; Zick A; Chertin B; Koulikov D; Sonnenblick A; Rosenbaum E
    Front Med (Lausanne); 2023; 10():1221484. PubMed ID: 37840996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
    Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
    Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-based postresection follow-up strategy for hepatocellular carcinoma patients.
    Fu Y; Li X; Yang Z; Li S; Pan Y; Chen J; Wang J; Hu D; Zhou Z; Xu L; Chen M; Zhang Y
    Cancer; 2023 Feb; 129(4):569-579. PubMed ID: 36541017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of
    Zhuang Y; Lan S; Zhong W; Huang F; Peng J; Zhang S
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.